Repository logo
 

BBmix: a Bayesian beta-binomial mixture model for accurate genotyping from RNA-sequencing.

Accepted version
Peer-reviewed

Change log

Abstract

MOTIVATION: While many pipelines have been developed for calling genotypes using RNA-sequencing (RNA-Seq) data, they all have adapted DNA genotype callers that do not model biases specific to RNA-Seq such as allele-specific expression (ASE). RESULTS: Here, we present Bayesian beta-binomial mixture model (BBmix), a Bayesian beta-binomial mixture model that first learns the expected distribution of read counts for each genotype, and then deploys those learned parameters to call genotypes probabilistically. We benchmarked our model on a wide variety of datasets and showed that our method generally performed better than competitors, mainly due to an increase of up to 1.4% in the accuracy of heterozygous calls, which may have a big impact in reducing false positive rate in applications sensitive to genotyping error such as ASE. Moreover, BBmix can be easily incorporated into standard pipelines for calling genotypes. We further show that parameters are generally transferable within datasets, such that a single learning run of less than 1 h is sufficient to call genotypes in a large number of samples. AVAILABILITY AND IMPLEMENTATION: We implemented BBmix as an R package that is available for free under a GPL-2 licence at https://gitlab.com/evigorito/bbmix and https://cran.r-project.org/package=bbmix with accompanying pipeline at https://gitlab.com/evigorito/bbmix_pipeline.

Description

Journal Title

Bioinformatics

Conference Name

Journal ISSN

1367-4803
1367-4811

Volume Title

Publisher

Oxford University Press (OUP)

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Wellcome Trust (220788/Z/20/Z)
Medical Research Council (MC_UU_00002/4)
National Institute for Health and Care Research (IS-BRC-1215-20014)
This work was co-funded by the Wellcome Trust (WT220788), the MRC (MC_UU_ 00002/4) and supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). M.L. , A.B and C.P were supported by the MRC/Arthritis Research UK award: Maximising Therapeutic Utility in RA (MATURA) (Grant MR-K015346). The Pathobiology of Early Arthritis Cohort (PEAC) was supported by funding from the MRC (grant number G0800648).

Relationships

Is derived from: